140 related articles for article (PubMed ID: 26711107)
21. Human papillomavirus integration: detection by in situ hybridization and potential clinical application.
Evans MF; Cooper K
J Pathol; 2004 Jan; 202(1):1-4. PubMed ID: 14694515
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus is not associated with breast carcinoma.
Yavuzer D; Salepci T; Karadayi N; Baloglu H; Kucukodaci Z
Breast Cancer Res Treat; 2010 Aug; 122(3):899-900. PubMed ID: 20521097
[No Abstract] [Full Text] [Related]
23. Prognostic significance of HPV physical status and integration sites in cervical cancer.
Nambaru L; Meenakumari B; Swaminathan R; Rajkumar T
Asian Pac J Cancer Prev; 2009; 10(3):355-60. PubMed ID: 19640172
[TBL] [Abstract][Full Text] [Related]
24. No evidence of the involvement of the Fas -670 promoter polymorphism in cervical cancer in situ.
Engelmark MT; Renkema KY; Gyllensten UB
Int J Cancer; 2004 Dec; 112(6):1084-5. PubMed ID: 15316939
[No Abstract] [Full Text] [Related]
25. Human papillomavirus 16 E2 interacts with neuregulin receptor degradation protein 1 affecting ErbB-3 expression in vitro and in clinical samples of cervical lesions.
Paolini F; Curzio G; Melucci E; Terrenato I; Antoniani B; Carosi M; Mottolese M; Vici P; Mariani L; Venuti A
Eur J Cancer; 2016 May; 58():52-61. PubMed ID: 26963794
[TBL] [Abstract][Full Text] [Related]
26. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions.
Steenbergen RD; Snijders PJ; Heideman DA; Meijer CJ
Nat Rev Cancer; 2014 Jun; 14(6):395-405. PubMed ID: 24854082
[TBL] [Abstract][Full Text] [Related]
27. Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions.
Chaiwongkot A; Vinokurova S; Pientong C; Ekalaksananan T; Kongyingyoes B; Kleebkaow P; Chumworathayi B; Patarapadungkit N; Reuschenbach M; von Knebel Doeberitz M
Int J Cancer; 2013 May; 132(9):2087-94. PubMed ID: 23065631
[TBL] [Abstract][Full Text] [Related]
28. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
[TBL] [Abstract][Full Text] [Related]
29. Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16.
Hong D; Liu J; Hu Y; Lu X; Li B; Li Y; Hu D; Lu W; Xie X; Cheng X
BMC Cancer; 2017 Feb; 17(1):136. PubMed ID: 28202002
[TBL] [Abstract][Full Text] [Related]
30. High level HPV-16 E7 oncoprotein expression correlates with reduced pRb-levels in cervical biopsies.
Fiedler M; Müller-Holzner E; Viertler HP; Widschwendter A; Laich A; Pfister G; Spoden GA; Jansen-Dürr P; Zwerschke W
FASEB J; 2004 Jul; 18(10):1120-2. PubMed ID: 15155561
[TBL] [Abstract][Full Text] [Related]
31. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
Liu SS; Tsang PC; Chan KY; Cheung AN; Chan KK; Leung RC; Ngan HY
Tumour Biol; 2008; 29(2):105-13. PubMed ID: 18515988
[TBL] [Abstract][Full Text] [Related]
32. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
33. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.
Li W; Wang W; Si M; Han L; Gao Q; Luo A; Li Y; Lu Y; Wang S; Ma D
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1355-61. PubMed ID: 18478264
[TBL] [Abstract][Full Text] [Related]
34. APOBEC3G is increasingly expressed on the human uterine cervical intraepithelial neoplasia along with disease progression.
Iizuka T; Wakae K; Nakamura M; Kitamura K; Ono M; Fujiwara H; Muramatsu M
Am J Reprod Immunol; 2017 Oct; 78(4):. PubMed ID: 28590025
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology.
Nkili-Meyong AA; Moussavou-Boundzanga P; Labouba I; Koumakpayi IH; Jeannot E; Descorps-Declère S; Sastre-Garau X; Leroy EM; Belembaogo E; Berthet N
Sci Rep; 2019 Feb; 9(1):1504. PubMed ID: 30728408
[TBL] [Abstract][Full Text] [Related]
36. Correspondence on "Human papillomavirus-independent cervical cancer" by Fernandes
Regauer S; Reich O; Kashofer K
Int J Gynecol Cancer; 2022 Apr; 32(4):581. PubMed ID: 35169071
[No Abstract] [Full Text] [Related]
37. Lack of association between p53 codon-72 polymorphism and squamous intraepithelial lesions in women with, or at risk for, human immunodeficiency virus and/or human papillomavirus infections.
Rezza G; Giuliani M; Garbuglia AR; Serraino D; Cappiello G; Migliore G; Branca M; Benedetto A; Ippolito G
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):565-6. PubMed ID: 11352871
[No Abstract] [Full Text] [Related]
38. An increase in DNA double-strand breaks, induced by Ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events.
Winder DM; Pett MR; Foster N; Shivji MK; Herdman MT; Stanley MA; Venkitaraman AR; Coleman N
J Pathol; 2007 Sep; 213(1):27-34. PubMed ID: 17642065
[TBL] [Abstract][Full Text] [Related]
39. p53 polymorphism and risk of cervical cancer.
Helland A; Langerød A; Johnsen H; Olsen AO; Skovlund E; Børresen-Dale AL
Nature; 1998 Dec; 396(6711):530-1; author reply 532. PubMed ID: 9859987
[No Abstract] [Full Text] [Related]
40. Human papillomavirus genotypes among women with HIV: implications for research and prevention.
Chaturvedi AK; Goedert JJ
AIDS; 2006 Nov; 20(18):2381-3. PubMed ID: 17117025
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
